SCHEMBL12440426

SCHEMBL12440426

Clc1ccc(-c2ccc(CCc3ccc(CN4CCOCC4)cc3)nc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.57
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
USP2 O75604 1/20 0.53
TSHR P16473 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
AOC3 Q16853 2/20 0.48
KCNH2 Q12809 1/20 0.48
LSS P48449 1/20 0.48
ALDH1A1 P00352 1/20 0.46
AKR1C3 P42330 1/20 0.46
AURKA O14965 1/20 0.45
CHEK1 O14757 2/20 0.45
ACHE P22303 1/20 0.45
MCHR1 Q99705 1/20 0.43
JAK2 O60674 1/20 0.43
KDM4E B2RXH2 1/20 0.43
SLC2A1 P11166 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12440536 0.88 KDM4E (0.55) HRH3LSSALDH1A1CHEK1MCHR1
SCHEMBL12441452 0.87 KDM4E (0.58) HRH3LSSALDH1A1CHEK1MCHR1
SCHEMBL19291923 0.82 SRC (0.52) HRH3MEN1KMT2ANPC1RAB9A
SCHEMBL4518384 0.79 MCHR1 (0.53) HRH3MEN1KMT2AUSP2TSHR
SCHEMBL12440554 0.79 CHKA (0.47) HRH3LSSALDH1A1MCHR1KDM4E
SCHEMBL12441111 0.79 LSS (0.41) HRH3LSSACHEMCHR1SLC2A1
4-(4-Chlorobenzyl)Morpholine SCHEMBL4103722 0.78 HRH3 (0.74) HRH3MEN1KMT2AUSP2TSHR
SCHEMBL12440425 0.75 MCHR1 (0.58) HRH3ALDH1A1CHEK1ACHEMCHR1
SCHEMBL12440218 0.75 MCHR1 (0.45) HRH3NPSR1LSSALDH1A1MCHR1
SCHEMBL12441461 0.74 MCHR1 (0.57) HRH3TSHRCHEK1MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2357173-A1 New alkyne compounds with MCH-antagonistic activity and medicaments containing them Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2011-08-17 EP disclosed